Previous studies have also demonstrated that higher CSF CHI3L1 levels in individuals with mild AD-type dementia, compared to healthy controls [139], suggesting that CHI3L1 has potential to discriminate AD from other forms of dementia and be a predictor of disease progression [36, 50, 142]. Here, CHI3L1 is linked to Alzheimer disease.